Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 2.000
+0.010 (0.50%)
Sep 18, 2026, 4:00 PM EST
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 197.56 million as of September 18, 2026. Its market cap has increased by 23.47% in one year.
Market Cap
197.56M
Enterprise Value
212.76M
Revenue
117.33M
Ranking
n/a
PE Ratio
18.19
Stock Price
2.00
ChartMarket Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 197.56M, a decrease of -6.64%. That is a compound annual growth rate of -0.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 197.56M | 19.54% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Auxly Cannabis Group | 347.90M |
| Aurora Cannabis | 346.36M |
| Cardiol Therapeutics | 306.08M |
| TerrAscend | 281.35M |
| Organigram Global | 208.69M |
| BioSyent | 181.85M |
| Medexus Pharmaceuticals | 157.13M |
| Grown Rogue International | 149.96M |